<

NANOBIOTIX (EPA:NANO) Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation

Transparency directive : regulatory news

02/04/2024 22:15



Other stories

23/04/2024 03:30
23/04/2024 09:13
22/04/2024 19:33
22/04/2024 20:34
23/04/2024 08:31
22/04/2024 21:18
23/04/2024 07:15
23/04/2024 04:27
22/04/2024 21:27
23/04/2024 07:05
23/04/2024 08:02
23/04/2024 04:04
23/04/2024 04:13
23/04/2024 05:42
23/04/2024 09:06
22/04/2024 18:38
22/04/2024 18:52
22/04/2024 19:32
23/04/2024 04:00
23/04/2024 03:49
22/04/2024 20:16
23/04/2024 02:42
23/04/2024 01:11
22/04/2024 23:56
22/04/2024 22:34
22/04/2024 22:52
23/04/2024 08:29
23/04/2024 08:41
23/04/2024 08:29
23/04/2024 00:38
22/04/2024 18:16
22/04/2024 18:04
22/04/2024 12:59
21/04/2024 21:31
23/04/2024 05:30
22/04/2024 07:45
22/04/2024 23:31
23/04/2024 03:15